NIH
-
What makes us human?
Using computational tools to search for the genetic basis of what makes us human, Vanderbilt Assistant Professor of Biomedical Informatics Tony Capra and colleagues at the University of California-San Francisco have identified promising candidate regions. Read MoreNov 22, 2013
-
Therapeutic target for synovial sarcoma
Inhibitors of a signaling pathway that is critical to synovial sarcoma tumorigenesis may be useful treatments for this aggressive cancer. Read MoreNov 21, 2013
-
Vanderbilt, Leipzig research collaboration sees strong results
During the past two weeks, the fifth international symposium between Leipzig and Vanderbilt universities was held on the Vanderbilt campus, as seven Leipzig faculty members presented a series of chemical biology-related lectures. Read MoreNov 14, 2013
-
Molecular circuits in ovarian cancer
Vanderbilt researchers have used bioinformatics analysis of gene expression data to describe molecular “circuits” that drive ovarian cancer. Read MoreNov 13, 2013
-
iPads help late-speaking children with autism develop language
The iPad you use to check email, watch episodes of "Mad Men" and play Words with Friends may hold the key to enabling children with autism to express themselves through speech. Read MoreNov 12, 2013
-
Amish aid study of Parkinson genetics
Amish populations are valuable for genetic research because of their isolation, shared ancestry and homogeneous lifestyles. Read MoreNov 11, 2013
-
Defusing ‘C. diff’ infection
Clostridium difficile on the intestinal lining. (Wellcome Images) Clostridium difficile (“C. diff”) infection is a leading cause of hospital-associated diarrhea, and the frequency and severity of infections are on the rise. D. Borden Lacy, Ph.D., associate professor of Pathology, Microbiology and Immunology, and colleagues recently demonstrated that the C. Read MoreNov 8, 2013
-
Neurotransmitter’s role in bone balance
Removal of the neurotransmitter norepinephrine from the space outside cells plays an important role in the regulation of bone remodeling. Read MoreNov 7, 2013
-
Breast SPORE lands NCI renewal
Vanderbilt-Ingram Cancer Center’s Breast Specialized Program of Research Excellence (SPORE) has been awarded a third round of funding from the National Cancer Institute (NCI). Read MoreNov 7, 2013
-
VU study sheds new light on DNA replication
David Cortez, Ph.D., and his Vanderbilt colleagues report new findings that shed light on fundamental processes involved in DNA replication and have implications for cancer therapies that target these processes. Read MoreNov 7, 2013
-
Even in the dark, brain “sees” its own body’s movement
With the help of computerized eye trackers, new research finds that at least 50 percent of people can see the movement of their own hand even in the absence of all light. Read MoreOct 30, 2013
-
Preserving antibiotic arsenal for TB
Clinicians should be cautious about prescribing newer fluoroquinolone antibiotics to patients with TB risk factors; doing so may jeopardize the use of these agents against TB. Read MoreOct 30, 2013
-
Tool predicts risk for developmental delays in early childhood
A non-invasive measure of electrical brain activity in preterm infants predicts cognitive and communication functioning during early childhood, according to a new Vanderbilt University study. Read MoreOct 28, 2013
-
Targets of SIN drive cell division
Vanderbilt researchers have identified a key regulator of cell division. Read MoreOct 25, 2013
-
Shining a light on night blindness
Vanderbilt researchers are studying how mutations in the receptor for light, rhodopsin, cause light blindness. Read MoreOct 24, 2013
-
Memorial Oct. 21 for Ellen Fanning, ALS walk Oct. 26
Please join in celebrating the life of Ellen Fanning, Stevenson Professor of Biological Sciences and a professor of the Howard Hughes Medical Institute, on Monday, Oct. 21, at 2 p.m., in Benton Chapel. Read MoreOct 18, 2013
-
Pharmacogenomic testing costs studied
A research team led by Josh Peterson, M.D., MPH, assistant professor of Biomedical Informatics and Medicine, and John Graves, Ph.D., assistant professor of Preventive Medicine, will study the cost-effectiveness of testing patients’ risk of adverse gene-drug interactions. Read MoreOct 17, 2013
-
VUCast: Startling brain-related study on critically ill patients
In the latest VUCast: ICU patients are leaving hospitals with a dementia-like disease; What’s the fate of the Republican Party?; Hear from Pulitzer Prize-winning author and Distinguished Visiting Professor Jon Meacham; and It's time to celebrate -- the Rate My Professor 2013 rankings are in. All this and more in Vanderbilt’s online newscast. Watch now. Read MoreOct 16, 2013
-
Relaxin combats insulin resistance
The hormone relaxin may offer a novel approach for treating diet-induced insulin resistance. Read MoreOct 16, 2013
-
Magnesium impacts vitamin D status
Magnesium and vitamin D appear to work together to reduce risk of death from cardiovascular disease and colorectal cancer. Read MoreOct 14, 2013